Yifan Zhai insider trades
Open-market stock purchases and sales by Yifan Zhai, Chief Medical Officer at Ascentage Pharma Group International, from SEC Form 4 filings since May 20, 2026.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| May 21, 2026 | AAPG Ascentage Pharma Group International | Bought (not open market) | — |
| May 21, 2026 | AAPG Ascentage Pharma Group International | Bought (not open market) | — |
| May 20, 2026 | AAPG Ascentage Pharma Group International | Bought (not open market) | — |
| May 20, 2026 | AAPG Ascentage Pharma Group International | Bought (not open market) | — |
| May 20, 2026 | AAPG Ascentage Pharma Group International | Bought (not open market) | — |
| May 20, 2026 | AAPG Ascentage Pharma Group International | Bought (not open market) | — |
| May 20, 2026 | AAPG Ascentage Pharma Group International | Bought (not open market) | — |
| May 20, 2026 | AAPG Ascentage Pharma Group International | Bought (not open market) | — |
| May 20, 2026 | AAPG Ascentage Pharma Group International | Bought (not open market) | — |
| May 20, 2026 | AAPG Ascentage Pharma Group International | Bought (not open market) | — |
Companies traded
- AAPG Ascentage Pharma Group International: other filings, last May 21, 2026